// App-Quantinova.ai

PP22-2 : FSH Levels Predict Ongoing Bone Loss in Premenopausal Women Treated for Breast Cancer More Than a Year after Treatment

Researchers

Presenter

  • Laila Shaheen Tabatabai

Principal Investigators

  • Susan L. Stewart

  • Joan R. Bloom

  • Deborah Sellmeyer

Medical Centers

  • Johns Hopkins Bayview Medical Center, Baltimore, MD

  • The Johns Hopkins Hospital, Baltimore, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Premature ovarian failure

  • Breast cancer

  • Osteoporosis

  • Solid malignancies

Biomarkers

  • Follicle-stimulating hormone

  • High sensitivity C-reactive protein

  • Bone Mineral Density

Drug/Treatment

  • Alora

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved